dCDK9-202 |
dCDK9-202 : Degrader (PROTAC) of CDK9
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CDK9 |
|
Degrader (PROTAC)
10 nM, up to 25 nM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
dCDK9-202 was evaluated for its target selectivity in the TC-71 cell line. Among CDKs, compound dCDK ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
dCDK9-202 was highly potent and effective in the inhibition of multiple cancer cell lines and achiev ...
Potency Cellular
In Vitro
CDK9
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.5c01111
In Vivo Validations
Mouse
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
0.3 h
Systemic clearance:
312 mL/min/Kg
Cmax:
280 ng/mL
Area Under the Curve::
116 h*ng/mL
Volume of Distribution at Steady-State:
7.1 L/Kg
DOI Reference: 10.1021/acs.jmedchem.5c01111
Negative Control Compounds
canSAR7437559
Notes: dCDK9-202Me was not able to degrade CDK9 with a Dmax of only 5% and IC50 >1000 nM in cell growth inhibition assay
Chemical Information
| Molecular Formula | C40H49N7O7S2 |
| SMILEs | CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(C(=O)CCCCCCCN4Cc5cc6c(cc5C4)C(=O)N(C4CCC(=O)NC4=O)C6=O)CC3)s2)o1 |
| InChI | InChI=1S/C40H49N7O7S2/c1-40(2,3)30-19-41-32(54-30)23-55-34-20-42-39(56-34)44-35(50)24-12-15-46(16-13-24)33(49)9-7-5-4-6-8-14-45-21-25-17-27-28(18-26(25)22-45)38(53)47(37(27)52)29-10-11-31(48)43-36(29)51/h17-20,24,29H,4-16,21-23H2,1-3H3,(H,42,44,50)(H,43,48,51) |
| Molecular weight | 803.31 Da |
| AlogP | 5.655600000000006 |
| HBond acceptors | 14 |
| HBond donors | 2 |
| Atoms | 105 |